Skip to main content
SpringerLink
Log in

Response to Micha et al. (2022) talc powder and ovarian cancer: what is the evidence?

  • Correspondence
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability statement

All data generated or analysed during this study are included in this published article and its references.

References

  1. Micha J, Rettenmaier M, Bohart R (2022) Talc powder and ovarian cancer: what is the evidence? Arch Gynecol Obstet 306(4):931–933

    Article  PubMed  Google Scholar 

  2. Steffen JE et al (2020) Serous ovarian cancer caused by exposure to asbestos and fibrous talc in cosmetic talc powders—a case series. J Occup Environ Med 62(2):e65–e77

    Article  CAS  PubMed  Google Scholar 

  3. Tran T et al (2019) Talc, asbestos, and epidemiology: corporate influence and scientific incognizance. Epidemiology 30(6):783–788

    Article  PubMed  PubMed Central  Google Scholar 

  4. Penninkilampi R, Eslick GD (2018) Perineal talc use and ovarian cancer: a systematic review and meta-analysis. Epidemiology 29(1):41–49

    Article  PubMed  Google Scholar 

  5. Egilman D et al (2020) Evidence that cosmetic talc is a cause of ovarian cancer. Gynecol Pelvic Med. 4:213

    Google Scholar 

  6. Sjosten AC, Ellis H, Edelstam GA (2004) Retrograde migration of glove powder in the human female genital tract. Hum Reprod 19(4):991–995

    Article  CAS  PubMed  Google Scholar 

  7. Woolen S, Lazar A, Smith-Bindman R (2022) Association between the frequent use of perineal talcum powder products and ovarian cancer: a systematic review and meta-analysis. J Gen Intern Med 37(10):2526–2532

    Article  PubMed  PubMed Central  Google Scholar 

  8. Meinhold-Heerlein I et al (2016) The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet 293(4):695–700

    Article  PubMed  Google Scholar 

  9. Appel JD et al (1988) Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA. Proc Natl Acad Sci USA 85(20):7670–7674

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors received no financial support for this article. D.S.E. serves as an expert witness in litigation at the request of people who claim injuries resulting from the use of talcum powders. T.H.T. serves as a consultant in talc litigation. Dr. Egilman was not compensated for work on this article. T.H.T was not compensated by law firms for work on this article.

Author information

Authors and Affiliations

  1. Never Again Consulting, Attleboro, MA, USA

    Triet Hao Tran

  2. Department of Family Medicine, Brown University, Providence, USA

    David Egilman

Authors
  1. Triet Hao Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Egilman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors were involved in the conception of this work, analysis of primary resources. Triet Tran and Dr. David Egilman drafted the work and critically revised it for important intellectual content. All authors gave final approval of the version to be published. David Egilman agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Triet Hao Tran.

Ethics declarations

Conflict of interest

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: D.S.E. serves as an expert witness in litigation at the request of people who claim injuries resulting from the use of talcum powders. T.H.T. works for D.S.E. Dr. Egilman was not compensated for work on this article. T.H.T was not compensated by law firms for work on this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tran, T.H., Egilman, D. Response to Micha et al. (2022) talc powder and ovarian cancer: what is the evidence?. Arch Gynecol Obstet 308, 1907–1908 (2023). https://doi.org/10.1007/s00404-022-06883-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-022-06883-9

Search

Navigation